MedPath

Pain and Medication Use Following Surgery

Not Applicable
Completed
Conditions
Opioid Use
Interventions
Behavioral: Information Sheet
Behavioral: Deterra Drug Deactivation System
Registration Number
NCT03179566
Lead Sponsor
University of Michigan
Brief Summary

Patients will be randomized to one of two interventions intended to facilitate safe disposal of opioids after cessation following surgery. For pragmatic reasons, participants will be randomized by day to either the information sheet or the disposal bag using a block randomization schedule. To ensuring adequate sample size, patients will be enrolled for a \~4-week period following the 2-week usual care run in period. In the event that the sample size estimate has not been reached after the 4-week intervention period, additional patients will be enrolled accordingly.

Detailed Description

The lack of evidence-based guidelines for postoperative opioid prescribing has contributed to a surplus of opioid pills within our patients' homes and communities, increasing the potential for diversion and nonmedical use. A recent study suggests that for outpatient general surgery procedures, roughly 72% of prescribed opioids go unused. Current opioid disposal options are limited to DEA-authorized opioid collectors, including select law enforcement agencies, pharmacies, or organized pill drop events, and many patients remain unaware of these avenues. Several studies have found that few patients have knowledge about opioid disposal options and even fewer dispose of their unconsumed opioids.

Unconsumed opioids pose a diversion risk. In the 2011 National Survey on Drug Use and Health, 70.8% of those who used a prescription medication non-medically obtained the medication from a friend or relative, with or without their knowledge. Additionally, nonmedical prescription opioid use is a common pathway to heroin use. Importantly, over 80% of young intravenous drug users report initiation of prescription opioid misuse prior to heroin.

Considering that 40% of the prescriptions written by surgeons are for opioids and patients frequently have excess opioids and limited options for and/or knowledge of opioid disposal, the present study will provide patients with information and novel options for opioid disposal as part of the surgical care pathway.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
391
Inclusion Criteria
  • Scheduled for surgery at Michigan Medicine's East Ann Arbor Ambulatory Surgery & Medical Procedures Center
Read More
Exclusion Criteria
  • Unable to speak English
  • Inability to understand or complete the surveys
  • Other conditions that preclude meaningful participation in the study
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Deterra Drug Deactivation SystemInformation SheetAt discharge, patients will receive a Deterra Drug Deactivation System.
Deterra Drug Deactivation SystemDeterra Drug Deactivation SystemAt discharge, patients will receive a Deterra Drug Deactivation System.
Information SheetInformation SheetAt discharge, patients will receive an informational sheet detailing options for safe drug disposal
Primary Outcome Measures
NameTimeMethod
Drug disposal4 weeks post-surgery

Patient-reported disposal of left-over opioid medications in any manner

Secondary Outcome Measures
NameTimeMethod
Opioid disposal technique4 weeks post-surgery

Patient-reported technique for disposal of left-over opioid medications specifically assessing for safe disposal using recommended disposal methods

Trial Locations

Locations (1)

East Ann Arbor Ambulatory Surgery & Medical Procedures Center - Michigan Medicine

🇺🇸

Ann Arbor, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath